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Summary Xenografted artificial heterogeneous tumours (AHTs) were created by admixing, in a ratio of 9:1
or 1:9, two clonal subpopulations (designated as clones A and D) obtained from a heterogeneous human
colon adenocarcinoma. In unperturbed AHTs these percentages remain constant with increasing tumour size.
At average volumes of 250mm3, AHTs were X-irradiated (15 Gy) and changes in growth rate and
composition assayed. A and D cells exhibited equivalent levels of survival after in vivo irradiation as
determined by excision assay procedures. At about 2-3 weeks post-irradiation AHTs exhibited a significant
enrichment of the majority population in both the 1:9 or 9:1 A:D AHTs. Additional studies were
concomitantly performed to determine whether these changes were mostly a function of normal tissue damage
or of parenchymal tumour cell killing. In these studies, the normal tissue only was irradiated, tumour cells
were implanted one day after irradiation, and the composition of AHTs assayed as a function of time post-
irradiation. In these studies, similar shifts in composition with similar kinetics to that seen in the in situ
irradiations were found. We therefore propose that these compositional shifts are mainly a reflection of
radiation damage to the stromal microenvironment, which is consequently unable to support tumour growth
adequately leading to competitive exclusion of the minority subpopulation.
Many human solid cancers are clonally heterogeneous in
composition (Leith & Dexter, 1986; Dexter & Leith, 1986).
Mauro et al. (1986) and Hiddemann et al. (1986) have
shown that approximately one-third of all human colorectal
cancers contain two or more subpopulations based on flow
cytometric analysis of DNA content. In this regard, we have
been studying the biological characteristics of xenografted
artificial heterogeneous tumours (AHTs). These are
neoplasms comprised of admixtures of varying proportions
of clonally related subpopulations (designated as A and D)
originally derived from a human colon adenocarcinoma
(Dexter et al., 1981). Zonality and compositional stability
characteristics of unperturbed AHTs have been
experimentally described (Leith et al., 1985, 1987), and
efforts to model AHT behaviour biomathematically have
begun (Michelson et al., 1987a,b,c, 1988; Michelson, 1987).
We have recently reported the responses of AHTs to
treatment with single doses of mitomycin C (Leith et al.,
1988a) as part of initial studies to determine the general
nature of the response of multiclonal cancers to cytotoxic
therapy. A similar focus on AHT behaviour for mammary
carcinomas has been taken by Miller et al. (1987).
The tumour bed effect (TBE) is a well-documented
phenomenon in which pre-irradiation of normal tissues
modifies the subsequent growth behaviour of transplanted
neoplasms in the damaged region (Hewitt & Blake, 1968;
Urano & Suit, 1970; Jirtle et al., 1978; Trott & Kummemehr,
1983; Begg & Terry, 1983, 1984; Ito et al., 1985; Milas et al.,
1986). Due to the intimate relationship between tumour
parenchyma and normal tissue stroma (Siemann et al., 1981),
we thought that the relationship between TBE expression
and tumour heterogeneity warranted investigation. While
zonality and compositional stability aspects of unperturbed
colon AHTs have been described (Leith et al., 1987), it is
important to see if such characteristics would change in the
face of a stressing agent (i.e. ionising radiation) that damages
the local microenvironment, as this may have relevance to
modelling of therapeutic concepts (e.g. Goldie & Coldman,
1979; Peters et al., 1986; Steel, 1988). In this manuscript, we
present data examining the composition of AHTs irradiated
in situ. These data are compared to changes in AHTs which
themselves have not been irradiated, but have been
transplanted to grow in previously irradiated sites (TBE
studies) (Leith et al., 1988b).
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Materials and methods
Tumour lines
The DLD-1 tumour system from which the clone A and D
subpopulations were obtained (Dexter et al., 1981) has been
described in detail. Briefly, the original biopsy specimen was
histologically heterogeneous, and this cell line was designated
as DLD-1. The A and D subpopulations were obtained by
soft agar cloning of the DLD-1 parent line. These lines are
distinct in morphology, in chromosome number and in their
responses to a number of chemical and physical cytotoxic
agents (Leith et al., 1982a,b, 1984). In vivo, clone A cells
produce poorly differentiated tumours, while D cells produce
moderately differentiated colon cancers (Dexter et al., 1981).
The A and D lines are maintained in tissue culture according
to previously published procedures (Leith et al., 1982a,b,
1984) and are replenished from frozen stock every 3-4
months.
Tumour disaggregation procedures
We have previously published procedures for disaggregation
of AHTs (Leith et al., 1985, 1987, 1988a). In the studies
reported here, we disaggregated solid tumours from
approximately days 7-70 after initial injection of cell
suspensions. Neoplasms were excised and multiple samples
per tumour were taken based on previously published
considerations of intratumour zonality (Fidler & Hart, 1983;
Leith et al., 1985, 1987; Michelson et al., 1988). Samples
were minced by scalpel, enzymatically dissociated (0.5%
trypsin-EDTA, 40min, 37°C; Grand Island Biological Co.,
Grand Island, NY), counted by haemocytometer and single
cells were seeded into 60mm plastic dishes (Becton-
Dickenson Laboratories, Rutherford, NH). Colonies
developed at 37°C in a humidified incubator (NAPCO,
Seattle, WA) with a 95% air 5% CO2 environment for
about 14 days. Colonies were then fixed and stained using
0.5% crystal violet in absolute methanol. Colonies
containing more than 50 cells were counted by eye for
estimation of the overall colony forming efficiency (CFE)
from each tumour.
Colony identification procedures
Each colony was visually inspected using phase contrast
microscopy during the course of development and
characterised as being of either clone A or clone D
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morphology, as each colony type has a unique appearance.
Photomicrographs of these clone A and D colonies have
appeared in several publications (Dexter et al., 1979, 1981).
To validate this procedure, as previously described (Leith et
al., 1985, 1987), we selected colonies of each morphological
type on a random basis from a number of different dishes
and from different tumours. Individual colonies were
trypsinised and these cells were allowed to proliferate until a
sufficient number were available for karotyping. Because
clone D or A cells contain 45-46 or 70-90 chromosomes
respectively (Dexter et al., 1981), we could absolutely
determine the ancestry of each colony and correlate this with
the morphological identification. In no case was a colony of
mixed chromosomal content noted, and in no case was there
any discrepancy between the morphological and karyotypic
assessments of colony identity. Therefore, we could measure
the overall CFE from each tumour, and also determine the
relative proportions of clone A and D cells for each
admixture condition. We assayed, on average from both
control and irradiated tumours, about 500 colonies per
sample or about 3,000 colonies from each tumour.
Therefore, even at long times post-irradiation, when tumour
compositions were changing, this would still yield adequate
numbers of the minority subpopulation for assessment. Also,
as we were aware that a selection process would occur at
long times post-irradiation, about twice the number of total
colonies were scanned so as to end up with 50-60 positive
identifications of colonies of the minority subpopulation.
Sampling procedures and mathematical techniques
Sampling procedures have been previously described (Leith
et al., 1985, 1987) and were based on the design of Wallen et
al. (1981). Generally six samples were taken from each
tumour for cell yield, compositional and clonogenic studies.
Estimates of the range in the amount of growth delay
produced were obtained by using the envelope of uncertainty
generated in the individual volumetric growth curves by the
standard errors of the mean on the tumour volumes as a
function of time post-irradiation. Changes in percentage
composition of AHTs with time were obtained by linear
regression of probit transformed data (Goldstein, 1964;
Finney, 1971).
Production of xenograft tumours
Mice bearing the nu/nu gene on an outbred Swiss
background obtained from the Charles River Breeding
Laboratories, Wilmington, MA were maintained in the
Animal Resources Facilities of Brown University,
Providence, RI. Mice were housed in a laminar flow hood
(Thoren Industries, Pittsburgh, PA) under specific pathogen-
free conditions, with sterilised food, bedding and water. Mice
of both sexes of approximately 5-7 weeks of age were used
in the studies.
For production of solid tumours, exponentially growing
cells were enzymatically removed (0.03% trypsin-EDTA;
GIBCO) from plastic flasks and resuspended in Hank's basic
salt solution (GIBCO). A total of 1 x 107 cells was injected
into the upper hip region in a total volume of 0.25ml. Mice
were ear tagged for individual monitoring, and were
separated into various groups on a random basis (Leith et
al., 1982a,b, 1984).
Solid tumours were obtained after injection of either pure
clone A or D cells alone, or after injection of 90% A: 10% D,
10%A:90%D or 50%A:50%D admixtures. Cells from
these initial admixtures were plated into 60mm diameter
plastic tissue culture dishes (Becton-Dickenson Labware,
Rutherford, NJ) with 5ml of RPMI-1640 medium and
colonies were allowed to develop. As clone A and D colonies
have distinctly different morphologies as described previously
(Dexter et al., 1979, 1981), it was possible to scan the
developing colonies (10 xmagnification, phase contrast
microscopy), identify them as being either A or D colonies,
and determine the relative percentage of each. As the colony-
forming efficiencies of exponentially growing cells were
essentially identical, these scans yielded the quoted values of
the percentage of A:D cells injected.
Measurement of tumour size
Tumours were measured by calipers in two orthogonal
diameters, and volumes calculated using the formula for a
prolate ellipsoid:
V(mm3)=Lx xW2/2
where L and W are the major and minor diameters
respectively. We have used this technique in previous work
(Leith et al., 1982a,b, 1984, 1988a,b). Average volumes with
standard errors for each tumour group were then plotted as
a function of time to obtain growth curves. Volume
measurements began at about day 7 post-injection, and
extended over the next 60-70 days. Animals with impaired
mobility leading to feeding problems due to tumour size or
with ulcerated tumours were killed. All measurements for all
tumour groups were made by a single individual.
X-irradiations
Mice were irradiated two at a time using a Philips 250kVp
X-ray machine operated at 20mA and 250kVp. A 4x6cm
collimator was used so that only the right hindlimb and
flank areas were exposed. Mice were lightly anaesthetised
with Metofane (methoxyflurane; Pitman-Moore, Washington
Crossing, NJ), restrained on a lucite irradiation platform and
allowed to recover before irradiations. Irradiation distances
were 33 cm and dose rates were 1 Gy per min. Exposure
doses were measured with a Victoreen R-meter (Victoreen
Co., Cleveland, OH) and converted to absorbed doses using
appropriate temperature, pressure and Roentgen-Gy
correction factors. For TBE studies, 15Gy was delivered one
day before cell injections. While we have previously
documented the effects of 15Gy irradiations on the TBE
(Leith et al., 1988b), we repeated these experiments with the
in situ irradiations to ensure comparability of results. For in
situ irradiations, tumours were irradiated at an average
volume of 250mm3. Control animals were sham irradiated.
Results
In Figure la-d, we show the cell yield (CY) data obtained
from disaggregation of the various tumour types as a
function of time after irradiation. There is a diminished yield
from all irradiated tumours, which is evident by about 2-3
weeks after exposure, and these values never recover to
control levels although there is convergence at long times
post-irradiation. This convergence is due to a decrease in the
CY from control tumours at large sizes. A decreased CY as
a function of radiation dose has also been demonstrated by
Vogler and Beck-Bornholdt (1988).
In Figure 2, we show the clonogenic cell survival from
irradiated tumours as a function of time post-irradiation.
These values have been normalised to the average colony
forming efficiencies (CFEs) of unirradiated, control
neoplasms. The CFEs for these controls were: clone A,
17.4% (1.0); clone D, 38.6% (3.7); 90% D: 10% A, 35.0%
(4.1); and 90%A:10%D, 20.9% (2.1) (values in parentheses
are standard errors of the means). There is no difference
among tumour groups in their survival versus time post-
irradiation. The survival level assayed immediately after
irradiation is about 6 x 10-4, which agrees well with
previously published data (Leith et al., 1984). At one day
post-irradiation survival in all groups had risen to about
2 x 10-3. Thereafter, the observed survivals rise smoothly
and attain values equal to control levels by about 10-15 days
post-irradiation (error values are not shown for purposes of
clarity, but the 95% confidence limits were typically about
8-30% of the mean survival). Therefore, even though a (CY24 J.T. LEITH et al.
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Figure 1 Changes in cell yield (cells per mg) from xenografted human colon carcinomas as a function of time after 15 Gy of X-
rays (control tumours 0, irradiated tumours 0). (a) Values from pure clone A tumours; (b) values from pure D tumours; (c)
values from artificial heterogeneous tumours of initial composition 10% A+90% D cells; (d) values from artificial heterogeneous
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Figure 2 Overall survival of tumour cells from disaggregated
neoplasms as a function of time after 15 Gy irradiation at time
zero. Data from pure D (0), pure A (0), 90%D+10%A (A)
and 90% A + 10% D (A) tumours are shown. Error bars (not
shown for purposes of clarity) were typically about 19% of mean
values (95% confidence limits 8-30%).
decreases, beginning at about 14 days post-irradiation, the
CFE was equal to that from unirradiated neoplasms.
In Figure 3, we show the compositional data obtained
from the differential scoring of colonies from the cell
survival studies after the in situ irradiations. In a, we show
data from the 90% A: 10% D tumours and in b, we show
similar results for the 90% D: 10% A neoplasms. Both sets of
data show similar trends. At about 15-20 days post-
irradiation, there is a clear indication of a change in the
percentage composition as compared to the stable
compositions of control tumours. Linear regression analysis
of the probit transformed data (Goldstein, 1964; Finney,
1971), indicates that the slopes of the compositional
responses seen in irradiated tumours in Figure 3a and b are
significantly different from zero, and are significantly
different from the 95% confidence limits on the slope of the
regression fit of the data from control tumours.
Extrapolation of the data from irradiated tumours indicates
that it would take approximately 4-6 months to reach a
composition level of 99.99% of the majority subpopulation.
Also, in Figure 3 we have included data from mice which
had tumours implanted after receiving 15Gy to the normal
tissue one day before implantation of tumour cells. Note that
as these tumours grew in the damaged normal tissue, the
composition of these AHTs changed in exactly the same
manner and with the same timing as that seen for established
tumours irradiated in situ. These data provide strong
evidence that the noted changes in composition are a
function of normal tissue damage, and have little to do with
the direct cytotoxic effects of ionising radiation on
parenchymal tumour cells.
In Figure 4, we have attempted to compare the effects on
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a tumour bed, versus that seen when both normal tissue and
1.99 tumour are irradiated in situ. It is possible to do this by
comparing equivalent regions of the volumetric growth
9.9 curves. As the in situ irradiations were carried out when
19.8 tumours were approximately 250mm3 in volume, we have
used the time needed for tumours to grow to twice this size
98 ~e _oas an index of effect. As may be seen in Figure 4, there is a
98 09-00 _O.-U dependence of this doubling time on tumour composition.
95 _ oi'8 * For tumours irradiated with 15Gy in situ, doubling time
so- A - A A A increases from about 20 days for pure A neoplasms to about 90 ° D-E ^'A36 days for pure D tumours. This response appears to be
80 linearly related to composition with admixtures of
70 intermediate compositions (i.e. 50% A:50% D) showing
60 growth delays that would be predicted from the relative
50 I I i I growth times of pure A and D tumours. Also in Figure 4,
b we have plotted the volume doubling times of tumours
3.99 growing in irradiated stroma, as well as the doubling times
of unirradiated, control tumours. The time needed to grow
from about 250 to 500mm3 for the controls is about the
39.8 same for all admixture conditions: about 3 days. The change
in doubling time produced by the irradiation of the normal
99 _0e .o., tissue is also dependent on tumour composition. If the
98 .0> o *0, * doubling times of the control tumours are subtracted from 9 ° . the in situ and TBE times, and the ratios of in situ to TBE
95 times are then taken, it is found that the contribution of the
90 _ A An, A A...A..- TBE effect to the overall change in growth time is constant
for all tumour admixture conditions, and is about 33% of
80 the total effect at a dose level of 15Gy.
70 We have discussed in detail only the data obtained from
60 I I the pure A and D tumours and 90% A: 10% D and
50 10 20 30 40 50 60 70 80 10% A:90% D AHTs. Similar data for CY, CFE, percentage
Days composition and growth delay (Figure 4) were obtained for the 50%A:50%D AHTs. However, as we have previously
3 Composition of artificial heterogeneous tumours as a shown, 50%A:50%D admixtures are intrinsically not stable
)n of time after 15Gy of X-rays. In (a), data from tumours chang wit time in tured neoplam t apra
'oA+10%1D initial composition are shown, while in (b), and cadmxtu meof about% 9d ellas(t etralh
tom tumours of 10%A+90%D initial composition are an admixture of about 10%A:90%D cells (Leith et al.,
A represents compositional values from control, unirra- 1985). This also occurred in the present experiments.
neoplasms. 0 represents data from tumours irradiated in Superimposed on this shift for irradiated tumours was the
day zero at an average tumour volume of 250mm3. O additional selection from a 10%A:90%D situation to a
nts data from tumours that were implanted into normal situation even more enriched in D cells. Therefore, even
that had been given 15Gy of X-rays (day zero) one day though the selection process occurs in the 50% A:50% D
rradiation. AHTs and is consistent with other data, we have chosen to
present the data only from the stable 10% A:90% D and
90% A: 10% D AHTs.
40
15 Gy to tumour Discussion
The primary result of this research has been the
30 demonstration that radiation damage to normal tissue
stroma produces a situation in which the relative cellular
composition of AHTs changes with time. Further, the data
presented (Figure 4) for tumour composition in tumours
irradiated in situ, or for tumours growing in pre-irradiated
20 stroma (TBE situation) indicate that it is the normal tissue
injury per se and not the cytotoxic effects on tumour
parenchyma that controls these compositional responses. We
15Gy to tumour bed describe this as a process of competitive exclusion which
10 selects the subpopulation initially in the majority (Leith et | controls al., 1988a). These responses are likely to be due to an
inadequate response of irradiated stroma to the angiogenic
_____________ stimulus provided by proliferating tumour cells (Hill et al.,
1 1 1 1987).
0 25 50 75 100 As Begg & Terry (1984) and Milas et al. (1986) have
Percent clone A in tumour shown that TBE exists after fractionated as well as single
dose irradiation, and have therefore established the
ure 4 Plot of the time needed (days) for tumours to grow significance of the TBE effect for clinical radiotherapy, it is
m 250mm to 500mm3 (volume doubling time). 0 represents obviously important to perform fractionated studies on
a from tumours of varying proportions of clone A:clone D AHTs to determine if the selection processes still occur and
s irradiated in situ at an average volume of 250mm3. The A
resents data taken from tumours of varying composition are equally effective. Preliminary data indicate that this is
lanted into normal tissue 1 day after a 15Gy exposure, and indeed the case (Leith, unpublished data, 1988).
luated after reaching a volume of 250mm3. 0 represents data The recent review by Steel (1988) of concepts in combined
m control, unirradiated tumours of varying composition. modality therapy is relevant to our description of radiation-
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with regard to the sequence of application. As
subpopulations within heterogeneous neoplasms often show
diversity with regard to their responses to any cytotoxic
agent (Leith & Dexter, 1986; Dexter & Leith, 1986), the
number of subpopulations and their individual differential
sensitivites to cytotoxic agents, as well as integrity of the
tumour microenvironment at the start of, or at any point
during, therapy will impact on the ultimate results. Note that
for large single doses of X-rays, clone A and D tumours
respond equivalently in terms of acute cell survival and
repopulation kinetics (Figure 2). If there were a differential
sensitivity between subpopulations, then the ultimate
outcome after irradiation would be the product of the
relative sensitivities and percentages of the total clonogenic
population occupied within the neoplasm by each
subpopulation. For example, we have shown that clone A
cells are about 2.3 times more sensitive to mitomycin C than
are clone D cells (Leith et al., 1988a). Treating an AHT that
was 90% A: 10% D with different sequences of X-irradiation
and mitomycin C might produce different outcomes. From
the physiological rather than the cellular viewpoint, another
reflection of microenvironmental damage is the production
of an increased fraction of hypoxic cells in recurrent tumours
(Leith, 1988).
If tumour multiclonality is noted in flow cytometric
analysis of a biopsy specimen, uncertainty in therapeutic
strategy may result (Hiddemann et al., 1986; Mauro et al.,
1986). Should such a finding alter the therapeutic approach
(i.e. patient stratification for possible assignment to
alternative treatment schemes)? This suggests that multiple
biopsy sampling may be needed to appreciate the
intratumour 'zonality' aspects of the architecture of the
neoplasm (Hiddemann et al., 1986; Fidler & Hart, 1983;
Leith et al., 1987).
Effective but not totally curative cytotoxic therapy will
also produce a situation in which the ultimate survival of a
minority subpopulation(s) will become stochastic in nature.
In this regard, the selection process produced by radiation
damage to stroma would suggest that induction of new
subpopulations with different (e.g. drug resistant) properties
as postulated by the mutation hypothesis of Goldie and
Coldman (1979) may not be as important as might be first
thought, because the probability of extinction of new
subpopulations arising in a damaged microenvironment
might concomitantly be much higher (Michelson et al.,
1987a).
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